Medical News

RSS

CHUM receives $1.25M donation from Pfizer Canada to set up patient health education program

The Fondation du Centre hospitalier de l'Université de Montréal (CHUM) has received a $1.25 million donation from Pfizer Canada for a patient health education program to be set up at CHUM.

4 Feb 2010

BioMarin Pharmaceutical signs stock purchase agreement to acquire LEAD Therapeutics

BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.

4 Feb 2010

Clinic closure leaves indigent dialysis patients looking for treatment

A clinic closure in Atlanta has patients and clinic officials struggling to find new providers that will treat low-income patients who need kidney dialysis, The Associated Press reports.

4 Feb 2010

"Knowledge deficit" about methadone responsible for resulting deaths

In a unique and comprehensive literature review of poisoning deaths involving opioids from 1999 -- 2009, the deaths involving methadone were found to be disproportionately high. Methadone represented less than five percent of all opioid prescriptions but is responsible for a third of the deaths. After four years of investigation, the major underlying cause was found to be fundamental misunderstandings about the properties of the medicine -- a "knowledge deficit" -- especially when converting patients from other opioids.

4 Feb 2010

Hillenbrand announces first-quarter fiscal 2010 results

Hillenbrand reported net revenue of $161.5 million for the first quarter of 2010, which ended December 31, 2009, a $5 million (3 percent) decline from the same period in fiscal 2009. The company posted net income of $29.5 million, a $3 million (11.3 percent) increase from the first quarter of last year. Earnings per diluted share for the first quarter of 2010 increased by $0.05 (11.6 percent) over the prior year period, from $0.43 to $0.48.

4 Feb 2010

Respite for overactive bladder: Powder Room lists public restrooms along the Sea-to-Sky Highway

The Powder Room, a national education program for people with overactive bladder, has compiled a list of public restrooms along the Sea-to-Sky Highway (Highway 99).

4 Feb 2010

CIGNA reports net income of $330M for fourth quarter 2009

CIGNA Corporation today reported shareholders’ net income of $330 million, or $1.19 per share, for the fourth quarter of 2009 compared with a shareholders’ net loss of $209 million, or $0.77 per share, for the same period last year.

4 Feb 2010

Expert available to discuss Lancet’s retraction of paper on autism study

Rae Sonnenmeier, clinical associate professor of communication sciences and disorders at the University of New Hampshire and staff member at UNH's Institute on Disability, is available to discuss the announcement yesterday (Feb. 2, 2010) by the medical journal The Lancet regarding the retraction of a paper that caused a 12-year international battle over the links between the three-in-one childhood vaccine MMR (measles, mumps, rubella) and autism.

4 Feb 2010

Manduka introduces Manduka PRO Black Cherry mat for yoga enthusiasts

Manduka (www.manduka.com), the world's leader in high performance yoga gear, announced today the introduction of the Manduka PRO Black Cherry—an iteration of the world-renowned Black Mat PRO—available for a limited time only in a hot new hue.

4 Feb 2010

Peripheral nerve stimulation promising for treatment of post-herpetic neuralgia

Doctors from the Mayo Clinic in Jacksonville, Florida showcased positive results of peripheral nerve stimulation (PNS) in a patient suffering from post-herpetic neuralgia (PHN), or pain after a herpes breakout.

4 Feb 2010

Phase Forward to participate in DIA Workshop and Clinical Trial Supply event

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, will participate in two industry events this month: The 13th Annual DIA Workshop in Japan for Clinical Data Management (Booths 4 and 5) and VIB Pharma’s 11th Annual Clinical Trial Supply (Booth 3).

4 Feb 2010

BioCryst Pharmaceuticals announces fourth-quarter and full-year 2009 financial results

BioCryst Pharmaceuticals, Inc. today announced financial results for the fourth quarter and year ended December 31, 2009.

4 Feb 2010

Sun Pharmaceutical Industries prohibited to purchase additional Taro shares while temporary injunction remains in effect

Taro Pharmaceutical Industries Ltd. today announced that the Supreme Court of the State of Israel (the “Supreme Court”) has ruled that Sun Pharmaceutical Industries Ltd. (“Sun”) may not exercise a warrant to purchase additional Taro shares while a previously ordered temporary injunction remains in effect.

4 Feb 2010

First Edition: February 4, 2010

Health care spending is taking an increasingly big bite out of the nation's economy, according to today's headlines.

4 Feb 2010

Secretaries to release new report on children’s health insurance

One year after President Obama signed the Children’s Health Insurance Program Reauthorization Act, Department of Health and Human Services Secretary Kathleen Sebelius and Department of Agriculture Secretary Tom Vilsack will visit the Mazique Parent Child Center to discuss efforts to identify and enroll children in health coverage and announce new steps the Departments are taking to insure more kids.

4 Feb 2010

February issue of Chest releases latest medical news

Inhaled corticosteroids (ICS) are widely used for the treatment of chronic obstructive pulmonary disease (COPD). However, new research suggests that ICS may only provide a modest benefit in reducing exacerbations in patients with COPD.

4 Feb 2010

Flexpoint Sensor Systems focuses on smaller contracts and production orders

Flexpoint Sensor Systems, Inc. http://www.flexpoint.com announced that the Company has modified the business model. In addition to focusing on large contracts in the medical bed and automotive industry, the company is more aggressively focusing on smaller contracts and production orders that produce immediate income for the Company.

4 Feb 2010

Discussion on IATA Chapter 17 compliance for temperature-sensitive products at 8th Cold Chain Summit

Pharma IQ, a division of IQPC, announces that Kevin O’Donnell Director & CTA of Tegrant Corporation and Chair of IATA’s Time & Temperature Task Force will discuss compliance with IATA’s revised Chapter 17 at the 8th Cold Chain Management and Temperature Control Summit.

From IQPC Ltd 4 Feb 2010

CTD seeks small molecule drug discovery and therapeutic antibody targets from academic researchers

A major centre created by the Medical Research Council (MRC) and MRC Technology (MRCT) in order to fast-track the discovery and development of novel drugs, opens its first call for targets today.

4 Feb 2010

Dundee Centre to help set the pace for national and international progress in cancer research

Dundee today (Thursday) becomes Scotland's first link in a unique chain of Cancer Research UK Centres that are being launched across the UK. The launch of the Dundee Centre coincides with World Cancer Day.

4 Feb 2010

Medical News

CHUM receives $1.25M donation from Pfizer Canada to set up patient health education program

BioMarin Pharmaceutical signs stock purchase agreement to acquire LEAD Therapeutics

Clinic closure leaves indigent dialysis patients looking for treatment

"Knowledge deficit" about methadone responsible for resulting deaths

Hillenbrand announces first-quarter fiscal 2010 results

Respite for overactive bladder: Powder Room lists public restrooms along the Sea-to-Sky Highway

CIGNA reports net income of $330M for fourth quarter 2009

Expert available to discuss Lancet’s retraction of paper on autism study

Manduka introduces Manduka PRO Black Cherry mat for yoga enthusiasts

Peripheral nerve stimulation promising for treatment of post-herpetic neuralgia

Phase Forward to participate in DIA Workshop and Clinical Trial Supply event

BioCryst Pharmaceuticals announces fourth-quarter and full-year 2009 financial results

Sun Pharmaceutical Industries prohibited to purchase additional Taro shares while temporary injunction remains in effect

First Edition: February 4, 2010

Secretaries to release new report on children’s health insurance

February issue of Chest releases latest medical news

Flexpoint Sensor Systems focuses on smaller contracts and production orders

Discussion on IATA Chapter 17 compliance for temperature-sensitive products at 8th Cold Chain Summit

CTD seeks small molecule drug discovery and therapeutic antibody targets from academic researchers

Dundee Centre to help set the pace for national and international progress in cancer research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News